SPRYCEL Side Effects

6880154-8 | Periorbital Oedema, Rash, Skin Exfoliation
on Feb 22, 2010 Female patient from UNITED STATES , 92 years of age, weighting 108.0 lb, was diagnosed with chronic myeloid leukaemia and was treated with Sprycel (View Usage). Patient experienced the following unwanted or unexpected effects: periorbital oedema, rash (What is rash?), skin exfoliation. Sprycel dosage: Interrupted On 02feb2010 + Restarted At 70mg Every Other Day. During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), NIFEREX (View Niferex Review and Niferex Label ), ALDACTONE (View Aldactone Review and Aldactone Label ).

6880150-0 | Rash
Patient was taking Sprycel (View Usage). Patient had the following side effects: rash (What is rash?) on Feb 17, 2010 from UNITED STATES Additional patient health information: Female patient , 92 years of age, was diagnosed with chronic myeloid leukaemia and. Sprycel dosage: .

6880149-4 | Dyspnoea, Lip Swelling, Nasal Congestion, Rash, Urticaria
Adverse event was reported on Mar 16, 2010 by a Female patient taking Sprycel (View Usage) (Dosage: 1df- 1/2 Tab Of 50mg Daily On 02feb10, 06feb10) was diagnosed with chronic myeloid leukaemia and. Location: UNITED STATES , 67 years of age, After Sprycel was administered, patient had the following side effects: dyspnoea, lip swelling, nasal congestion, rash (What is rash?), urticaria.

6880147-0 | Hepatic Enzyme Increased
on Feb 02, 2010 Female patient from UNITED STATES , 55 years of age, weighting 160.9 lb, was treated with Sprycel (View Usage). Patient experienced the following unwanted or unexpected effects: hepatic enzyme increased. Sprycel dosage: .


6880145-7 | No Adverse Event
on Feb 12, 2010 Female patient from UNITED STATES , 42 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Sprycel (View Usage). Patient had the following side effects: no adverse event. Sprycel dosage: .

6880144-5 | Dysstasia
Patient was taking Sprycel (View Usage). After Sprycel was administered, patient had the following side effects: dysstasia on Jan 14, 2010 from UNITED STATES Additional patient health information: Female patient , 72 years of age, weighting 169.8 lb, was diagnosed with chronic myeloid leukaemia and. Sprycel dosage: . During the same period patient was treated with LEVOXYL (View Levoxyl Review and Levoxyl Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), HYDROCODONE BITARTRATE (View Hydrocodone Bitartrate Review and Hydrocodone Bitartrate Label ), CENTRUM (View Centrum Review and Centrum Label ).

6880138-X | Bradycardia, Pleural Effusion
Adverse event was reported on Jan 12, 2010 by a Male patient taking Sprycel (View Usage) (Dosage: ) was diagnosed with chronic myeloid leukaemia and. Location: UNITED STATES , 62 years of age, Patient experienced the following unwanted or unexpected effects: bradycardia, pleural effusion.

6880134-2 | Pleural Effusion
on Jan 06, 2010 Female patient from UNITED STATES , 72 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Sprycel (View Usage). Patient had the following side effects: pleural effusion. Sprycel dosage: . Patient was hospitalized.

6880133-0 | Rash Erythematous
on Dec 18, 2009 Male patient from UNITED STATES , 53 years of age, weighting 160.9 lb, was diagnosed with chronic myeloid leukaemia and was treated with Sprycel (View Usage). After Sprycel was administered, patient had the following side effects: rash erythematous. Sprycel dosage: . During the same period patient was treated with COLCHICINE (View Colchicine Review and Colchicine Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), NORVASC (View Norvasc Review and Norvasc Label ).

6880129-9 | Malignant Neoplasm Progression
Patient was taking Sprycel (View Usage). Patient experienced the following unwanted or unexpected effects: malignant neoplasm progression on Dec 14, 2009 from UNITED STATES Additional patient health information: Female patient , 71 years of age, was diagnosed with gastrointestinal stromal tumour and. Sprycel dosage: For Approximately Two Months.

6880127-5 | Fatigue, White Blood Cell Count Decreased
Adverse event was reported on Dec 02, 2009 by a Female patient taking Sprycel (View Usage) (Dosage: ) was diagnosed with chronic myeloid leukaemia and. Location: UNITED STATES , 81 years of age, weighting 149.9 lb, Patient had the following side effects: fatigue, white blood cell count decreased. During the same period patient was treated with LIPITOR (View Lipitor Review and Lipitor Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), AMBIEN (View Ambien Review and Ambien Label ).

6880126-3 | Hepatic Enzyme Increased
on Nov 30, 2009 Male patient from UNITED STATES , 30 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Sprycel (View Usage). After Sprycel was administered, patient had the following side effects: hepatic enzyme increased. Sprycel dosage: . During the same period patient was treated with LORATADINE (View Loratadine Review and Loratadine Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), FLOVENT (View Flovent Review and Flovent Label ), MULTI VITAMINS (View Multi-vitamins Review and Multi-vitamins Label ).

6880122-6 | Rash, Swelling Face, Vulvovaginal Mycotic Infection, Weight Increased
on Nov 24, 2009 Female patient from UNITED STATES , 23 years of age, weighting 149.9 lb, was diagnosed with chronic myeloid leukaemia, nausea (What is nausea?) and was treated with Sprycel (View Usage). Patient experienced the following unwanted or unexpected effects: rash (What is rash?), swelling face, vulvovaginal mycotic infection, weight increased. Sprycel dosage: Alternating 100mg ? Tablet (50mg) Every Other Day. During the same period patient was treated with ZOFRAN (View Zofran Review and Zofran Label ), VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ), ASCORBIC ACID (View Ascorbic Acid Review and Ascorbic Acid Label ).

6880121-4 | Pleural Effusion
Patient was taking Sprycel (View Usage). Patient had the following side effects: pleural effusion on Nov 20, 2009 from UNITED STATES Additional patient health information: Male patient , 59 years of age, . Sprycel dosage: .

6880120-2 | Erythema, Swelling Face
Adverse event was reported on Nov 16, 2009 by a Male patient taking Sprycel (View Usage) (Dosage: ) . Location: UNITED STATES , 68 years of age, After Sprycel was administered, patient had the following side effects: erythema, swelling face.

6880119-6 | Pleural Effusion
on Jan 04, 2010 Male patient from UNITED STATES , 63 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Sprycel (View Usage). Patient experienced the following unwanted or unexpected effects: pleural effusion. Sprycel dosage: Dose Decreased To 70 Mg/day And Later Withdrawn.

6880117-2 | Fluid Retention
on Nov 11, 2009 Male patient from UNITED STATES , 68 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Sprycel (View Usage). Patient had the following side effects: fluid retention. Sprycel dosage: .

6880111-1 | Arthralgia, Swelling
Patient was taking Sprycel (View Usage). After Sprycel was administered, patient had the following side effects: arthralgia, swelling on Nov 12, 2009 from UNITED STATES Additional patient health information: Male patient , 32 years of age, was diagnosed with chronic myeloid leukaemia and. Sprycel dosage: . During the same period patient was treated with PEPCID (View Pepcid Review and Pepcid Label ), CENTRUM (View Centrum Review and Centrum Label ), OSCAL D (View Oscal D Review and Oscal D Label ), PHENERGAN (View Phenergan Review and Phenergan Label ), ZOFRAN (View Zofran Review and Zofran Label ), XANAX (View Xanax Review and Xanax Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), OXYCODONE (View Oxycodone Review and Oxycodone Label ).

6880109-3 | Pleural Effusion
Adverse event was reported on Oct 23, 2009 by a Male patient taking Sprycel (View Usage) (Dosage: ) . Location: UNITED STATES , 57 years of age, Patient experienced the following unwanted or unexpected effects: pleural effusion.

6880104-4 | Pregnancy
on Oct 14, 2009 Female patient from UNITED STATES , 24 years of age, was treated with Sprycel (View Usage). Patient had the following side effects: pregnancy (What is pregnancy?). Sprycel dosage: .

6880098-1 | Anaemia, Constipation, Dyspnoea, Nausea, No Therapeutic Response, Platelet Count Increased
on Sep 18, 2009 Female patient from UNITED STATES , 64 years of age, was treated with Sprycel (View Usage). After Sprycel was administered, patient had the following side effects: anaemia, constipation (What is constipation?), dyspnoea, nausea (What is nausea?), no therapeutic response, platelet count increased. Sprycel dosage: . During the same period patient was treated with TASIGNA (View Tasigna Review and Tasigna Label ).

6880097-X | Pleural Effusion, Pneumonia
Patient was taking Sprycel (View Usage). Patient experienced the following unwanted or unexpected effects: pleural effusion, pneumonia (What is pneumonia?) on Sep 14, 2009 from UNITED STATES Additional patient health information: Female patient , 63 years of age, . Sprycel dosage: .

6880096-8 | Arthralgia, Myalgia, Pleural Effusion
Adverse event was reported on Sep 08, 2009 by a Female patient taking Sprycel (View Usage) (Dosage: ) was diagnosed with chronic myeloid leukaemia and. Location: UNITED STATES , 68 years of age, Patient had the following side effects: arthralgia, myalgia, pleural effusion.

6880095-6 | Rash
on Sep 04, 2009 Female patient from UNITED STATES , 49 years of age, was treated with Sprycel (View Usage). After Sprycel was administered, patient had the following side effects: rash (What is rash?). Sprycel dosage: . During the same period patient was treated with SYNTHROID (View Synthroid Review and Synthroid Label ), TRICOR (View Tricor Review and Tricor Label ), IMIPRAMINE (View Imipramine Review and Imipramine Label ), NADOLOL (View Nadolol Review and Nadolol Label ).

6880091-9 | Cardiac Failure Congestive, Neutropenia, Pneumonia
on Sep 02, 2009 Female patient from UNITED STATES , 87 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Sprycel (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac failure congestive, neutropenia, pneumonia (What is pneumonia?). Sprycel dosage: . Patient was hospitalized.

6880090-7 | Pleural Effusion
Patient was taking Sprycel (View Usage). Patient had the following side effects: pleural effusion on Aug 25, 2009 from UNITED STATES Additional patient health information: Male patient , 80 years of age, was diagnosed with chronic myeloid leukaemia and. Sprycel dosage: . Patient was hospitalized.

6880089-0 | Lung Disorder, Pleural Effusion
Adverse event was reported on Aug 21, 2009 by a Female patient taking Sprycel (View Usage) (Dosage: ) was diagnosed with chronic myeloid leukaemia and. Location: UNITED STATES , 71 years of age, After Sprycel was administered, patient had the following side effects: lung disorder, pleural effusion. During the same period patient was treated with SOTALOL HCL (View Sotalol Hcl Review and Sotalol Hcl Label ), CALCIUM (View Calcium Review and Calcium Label ), NEXIUM (View Nexium Review and Nexium Label ), AMARYL (View Amaryl Review and Amaryl Label ), BUMEX (View Bumex Review and Bumex Label ), ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), FLONASE (View Flonase Review and Flonase Label ), NORVASC (View Norvasc Review and Norvasc Label ).

6880087-7 | Hypoaesthesia, Pain, Paraesthesia
on Aug 17, 2009 Male patient from UNITED STATES , 61 years of age, weighting 200.6 lb, was diagnosed with chronic myeloid leukaemia and was treated with Sprycel (View Usage). Patient experienced the following unwanted or unexpected effects: hypoaesthesia, pain (What is pain?), paraesthesia. Sprycel dosage: Duration:3 Years. During the same period patient was treated with FLOMAX (View Flomax Review and Flomax Label ), ZETIA (View Zetia Review and Zetia Label ).

6880084-1 | Rash Pruritic
on Aug 06, 2009 Female patient from UNITED STATES , 51 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Sprycel (View Usage). Patient had the following side effects: rash pruritic. Sprycel dosage: .

6880082-8 | Mucosal Inflammation
Patient was taking Sprycel (View Usage). After Sprycel was administered, patient had the following side effects: mucosal inflammation on Aug 03, 2009 from UNITED STATES Additional patient health information: Female patient , 38 years of age, was diagnosed with chronic myeloid leukaemia and. Sprycel dosage: Changed To 50mg Bid (1 Month).

6880081-6 | Renal Failure Chronic
Adverse event was reported on Aug 13, 2009 by a Female patient taking Sprycel (View Usage) (Dosage: Received For About 6-8 Weeks) was diagnosed with chronic myeloid leukaemia and. Location: UNITED STATES , 77 years of age, Patient experienced the following unwanted or unexpected effects: renal failure chronic. During the same period patient was treated with GLEEVEC (View Gleevec Review and Gleevec Label ).

6880078-6 | Pregnancy
on Jul 21, 2009 Male patient from UNITED STATES , 35 years of age, weighting 229.3 lb, was diagnosed with chronic myeloid leukaemia and was treated with Sprycel (View Usage). Patient had the following side effects: pregnancy (What is pregnancy?). Sprycel dosage: 2 Df = 2tabs;started 70mg, 2 Tab Daily About 4 Years Ago.

6880077-4 | Decreased Appetite, Fatigue, Rash
on Jul 22, 2009 Female patient from UNITED STATES , 77 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Sprycel (View Usage). After Sprycel was administered, patient had the following side effects: decreased appetite, fatigue, rash (What is rash?). Sprycel dosage: .

6880076-2 | Pregnancy
Patient was taking Sprycel (View Usage). Patient experienced the following unwanted or unexpected effects: pregnancy (What is pregnancy?) on Jul 21, 2009 from UNITED STATES Additional patient health information: Male patient , 35 years of age, weighting 229.3 lb, was diagnosed with chronic myeloid leukaemia and. Sprycel dosage: 2 Df = 2tabs;started 70mg, 2 Tab Daily About 4 Years Ago.

6880075-0 | Nausea
Adverse event was reported on Jul 15, 2009 by a Female patient taking Sprycel (View Usage) (Dosage: ) was diagnosed with chronic myeloid leukaemia and. Location: UNITED STATES , 65 years of age, Patient had the following side effects: nausea (What is nausea?). During the same period patient was treated with TASIGNA (View Tasigna Review and Tasigna Label ).

6880074-9 | Fluid Overload
on Jul 15, 2009 Female patient from UNITED STATES , 75 years of age, weighting 205.0 lb, was diagnosed with chromosome analysis abnormal and was treated with Sprycel (View Usage). After Sprycel was administered, patient had the following side effects: fluid overload. Sprycel dosage: . Patient was hospitalized.

6880062-2 | Headache
on Jun 09, 2009 Male patient from UNITED STATES , 50 years of age, weighting 246.9 lb, was diagnosed with chronic myeloid leukaemia and was treated with Sprycel (View Usage). Patient experienced the following unwanted or unexpected effects: headache (What is headache?). Sprycel dosage: . During the same period patient was treated with DYAZIDE (View Dyazide Review and Dyazide Label ), LASIX (View Lasix Review and Lasix Label ), POTASSIUM (View Potassium Review and Potassium Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), DARVOCET (View Darvocet Review and Darvocet Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), HYDREA (View Hydrea Review and Hydrea Label ), GLEEVEC (View Gleevec Review and Gleevec Label ).

6880061-0 | Headache, Nausea
Patient was taking Sprycel (View Usage). Patient had the following side effects: headache (What is headache?), nausea (What is nausea?) on Jun 05, 2009 from UNITED STATES Additional patient health information: Male patient , 50 years of age, weighting 229.3 lb, was diagnosed with chronic myeloid leukaemia and. Sprycel dosage: . During the same period patient was treated with TRICOR (View Tricor Review and Tricor Label ).

6880060-9 | Bone Disorder, Impaired Healing
Adverse event was reported on Oct 02, 2009 by a Male patient taking Sprycel (View Usage) (Dosage: ) was diagnosed with chronic myeloid leukaemia and. Location: UNITED STATES , 58 years of age, weighting 308.6 lb, After Sprycel was administered, patient had the following side effects: bone disorder, impaired healing. During the same period patient was treated with AVINZA (View Avinza Review and Avinza Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ), ACIPHEX (View Aciphex Review and Aciphex Label ), FLOMAX (View Flomax Review and Flomax Label ), EFFEXOR (View Effexor Review and Effexor Label ), NORVASC (View Norvasc Review and Norvasc Label ), LOPRESSOR (View Lopressor Review and Lopressor Label ), CELEBREX (View Celebrex Review and Celebrex Label ).

6879809-0 | Cerebral Infarction, Retinal Vein Occlusion
on Jul 15, 2010 Male patient from JAPAN , 84 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with Sprycel (View Usage). Patient experienced the following unwanted or unexpected effects: cerebral infarction, retinal vein occlusion. Sprycel dosage: . Patient was hospitalized.

6870932-3 | Brain Oedema, Fall, Subdural Haematoma
on Jul 20, 2010 Male patient from FRANCE , 73 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with Sprycel (View Usage). Patient had the following side effects: brain oedema, fall (What is fall?), subdural haematoma. Sprycel dosage: . During the same period patient was treated with SOLU MEDROL (View Solu-medrol Review and Solu-medrol Label ). Patient was hospitalized.

6867443-8 | Atrial Fibrillation, Pericardial Effusion, Pleural Effusion
Patient was taking Sprycel (View Usage). After Sprycel was administered, patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), pericardial effusion, pleural effusion on Jul 20, 2010 from FRANCE Additional patient health information: Male patient , 79 years of age, was diagnosed with chronic myeloid leukaemia and. Sprycel dosage: . Patient was hospitalized.

6867408-6 | Squamous Cell Carcinoma
Adverse event was reported on Jul 21, 2010 by a Male patient taking Sprycel (View Usage) (Dosage: ) was diagnosed with chronic myeloid leukaemia and. Location: GERMANY , 76 years of age, weighting 176.4 lb, Patient experienced the following unwanted or unexpected effects: squamous cell carcinoma.

6866380-2 | Anaemia, Infection, Liver Disorder, Malignant Neoplasm Progression, Nausea, Neutrophil Count Decreased, Platelet Count Decreased, Pulmonary Oedema, White Blood Cell Count Decreased
on Jul 12, 2010 Male patient from JAPAN , 35 years of age, weighting 145.5 lb, was diagnosed with chronic myeloid leukaemia, prophylaxis and was treated with Sprycel (View Usage). Patient had the following side effects: anaemia, infection (What is infection?), liver disorder, malignant neoplasm progression, nausea (What is nausea?), neutrophil count decreased, platelet count decreased, pulmonary oedema, white blood cell count decreased. Sprycel dosage: 12jun09-28jun09:70mg. 29jun09-05oct09,90mg. 21oct09-29nov09,60mg. During the same period patient was treated with CYTARABINE (Cytarabine Oofosphate Hydrate Cap) (View Cytarabine Review and Cytarabine Label ), HYDROXYCARBAMIDE (Cap) (View Hydroxycarbamide Review and Hydroxycarbamide Label ), RANITIDINE HCL TABS (View Ranitidine Hcl Tabs Review and Ranitidine Hcl Tabs Label ), POTASSIUM CHLORIDE (Tabs) (View Potassium Chloride Review and Potassium Chloride Label ), DOMIPHEN BROMIDE (Lozenge) (View Domiphen Bromide Review and Domiphen Bromide Label ), GARENOXACIN ORAL TABS (Garenoxacin Mesilate Hydrate) (View Garenoxacin Oral Tabs Review and Garenoxacin Oral Tabs Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), DEFERASIROX (Tab) (View Deferasirox Review and Deferasirox Label ). Patient was hospitalized and became disabled.

6863163-4 | Ascites, Hepatomegaly, Pleural Effusion, Pulmonary Arterial Hypertension, Respiratory Acidosis, Weight Increased
on Jul 16, 2010 Male patient from FRANCE , 37 years of age, was diagnosed with chronic myeloid leukaemia, asthma (What is asthma?) and was treated with Sprycel (View Usage). After Sprycel was administered, patient had the following side effects: ascites, hepatomegaly, pleural effusion, pulmonary arterial hypertension, respiratory acidosis, weight increased. Sprycel dosage: . During the same period patient was treated with VENTOLIN (View Ventolin Review and Ventolin Label ), SYMBICORT (Turbuhaler) (View Symbicort Review and Symbicort Label ). Patient was hospitalized.

6863136-1 | Pyrexia, Sepsis
Patient was taking Sprycel (View Usage). Patient experienced the following unwanted or unexpected effects: pyrexia, sepsis (What is sepsis?) on Jul 16, 2010 from GERMANY Additional patient health information: Male patient , 48 years of age, weighting 194.0 lb, was diagnosed with acute myeloid leukaemia and. Sprycel dosage: Interrupted 05-jun-2010. During the same period patient was treated with CYTARABINE (1 Df-1200 Units Not Specified. Interrupted 23may10) (View Cytarabine Review and Cytarabine Label ), DAUNORUBICIN HCL (View Daunorubicin Hcl Review and Daunorubicin Hcl Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), COTRIM (View Cotrim Review and Cotrim Label ), AMPICILLIN AND SULBACTAM (View Ampicillin And Sulbactam Review and Ampicillin And Sulbactam Label ), MICAFUNGIN SODIUM (View Micafungin Sodium Review and Micafungin Sodium Label ). Patient was hospitalized and became disabled.

6860856-X | Malignant Neoplasm Progression, Pleural Effusion
Adverse event was reported on Jul 15, 2010 by a Male patient taking Sprycel (View Usage) (Dosage: ) was diagnosed with acute lymphocytic leukaemia and. Location: JAPAN , 70 years of age, Patient had the following side effects: malignant neoplasm progression, pleural effusion.

6856802-5 | Atrial Fibrillation, Hypertension, Infection, Oedema, Palpitations, Pericarditis, Pleurisy
on Jul 13, 2010 Female patient from FRANCE , 80 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Sprycel (View Usage). After Sprycel was administered, patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), hypertension, infection (What is infection?), oedema, palpitations, pericarditis, pleurisy. Sprycel dosage: Capsules. During the same period patient was treated with COAPROVEL (View Coaprovel Review and Coaprovel Label ), CHONDROSULF (View Chondrosulf Review and Chondrosulf Label ), TANAKAN (View Tanakan Review and Tanakan Label ), OROCAL (View Orocal Review and Orocal Label ). Patient was hospitalized.

6855988-6 | Alanine Aminotransferase Increased, Anaemia, Cytomegalovirus Infection, Decreased Appetite, Diarrhoea, Epstein-barr Virus Infection, Histiocytosis Haematophagic, Influenza, Interstitial Lung Disease
on Jul 13, 2010 Female patient from JAPAN , 55 years of age, weighting 97.00 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Sprycel (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, anaemia, cytomegalovirus infection (What is cytomegalovirus infection?), decreased appetite, diarrhoea, epstein-barr virus infection, histiocytosis haematophagic, influenza, interstitial lung disease. Sprycel dosage: Interrupt On 21apr09 Restart On 20may At 50mg 2/1d 100 Mg 1/1 D From 30jun. During the same period patient was treated with MAXIPIME (View Maxipime Review and Maxipime Label ), MICAFUNGIN SODIUM (Inj) (View Micafungin Sodium Review and Micafungin Sodium Label ), AMIKACIN (View Amikacin Review and Amikacin Label ), VITAMIN B1 TAB (View Vitamin B1 Tab Review and Vitamin B1 Tab Label ), DEXTROSE (View Dextrose Review and Dextrose Label ), AMINO ACID + ELECTROLYTES (View Amino Acid + Electrolytes Review and Amino Acid + Electrolytes Label ), PLATELETS (View Platelets Review and Platelets Label ), GANCICLOVIR (Formulation: Inj) (View Ganciclovir Review and Ganciclovir Label ). Patient was hospitalized.

6848584-8 | Colitis Ulcerative, Iron Deficiency Anaemia
Patient was taking Sprycel (View Usage). Patient had the following side effects: colitis ulcerative, iron deficiency anaemia on Jul 13, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 39 years of age, weighting 176.4 lb, was diagnosed with chronic myeloid leukaemia and. Sprycel dosage: . Patient was hospitalized.